loader
Please Wait
Applying Filters...

Evonik Evonik

X

Information, Expiry & Status of FDA Orange Book Patents covering Temsirolimus

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 PF PRISM CV (8)

filter

01 8026276 (1)

02 8026276*PED (1)

03 8299116*PED (1)

04 8455539*PED (1)

05 8722700*PED (1)

06 8791097 (2)

07 8791097*PED (1)

filter

01 Blank (8)

filter

01 Y (1)

02 Blank (7)

filter

01 2024-01-25 (3)

02 2026-01-20 (1)

03 2026-07-20 (1)

04 2032-05-10 (2)

05 2032-11-10 (1)

URL Supplier Web Content
8791097
2032-05-10
U-1551
22088
METHOD OF TREATING PAPILLARY RENAL CELL CARCINOMA WITH TEMSIROLIMUS, IN THE ABSENCE OF INTERFERON ALPHA.
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8791097
2032-05-10
U-1550
22088
METHOD OF TREATING METASTATIC PAPILLARY RENAL CELL CARCINOMA WITH TEMSIROLIMUS.
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8026276
Y
2026-01-20
22088
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8026276*PED
2026-07-20
22088
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8299116*PED
2024-01-25
22088
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8455539*PED
2024-01-25
22088
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8791097*PED
2032-11-10
22088
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8722700*PED
2024-01-25
22088
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY